Fate Therapeutics Inc - Company Profile
Powered by
All the data and insights you need on Fate Therapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Fate Therapeutics Inc Strategy Report
- Understand Fate Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Fate Therapeutics Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
US20220275333A1 | Application | IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF | A61K35/17; A61P35/00; C12N15/102; C12N15/1138; C12N15/85; C12N15/907; C12N2506/45; C12N2510/00; C12N2800/80; C12N5/0646 | September 01, 2022 |
EP4045539A1 | Application | VERBESSERTER CHIMÄRER ANTIGENREZEPTOR FÜR DIE IMMUNEFFEKTORZELLZÜCHTUNG UND SEINE VERWENDUNG | A61K2039/5156; A61K39/0011; A61K48/005; A61P35/00; C07K14/70503; C07K14/7051; C07K16/28; C07K2317/622; C07K2319/03 | August 24, 2022 |
EP4041759A1 | Application | VERBESSERTER CHIMÄRER ANTIGENREZEPTOR FÜR DIE IMMUNEFFEKTORZELLZÜCHTUNG UND SEINE VERWENDUNG | A61K35/17; A61K38/00; A61P35/00; C07K14/7051; C07K16/2803; C07K2317/622; C07K2319/03 | August 17, 2022 |
US11413309B2 | Grant | Compositions and methods for immune cell modulation in adoptive immunotherapies | A61K31/436; A61K35/17; A61K35/28; A61K35/545; A61K38/09; A61K38/14; A61K38/212; A61K38/50; A61K45/06; C07K14/7051; C12N2510/00; C12N5/0636; Y02A50/30 | August 16, 2022 |
CN114901693A | Application | 用于免疫效应细胞工程化的增强的嵌合抗原受体和其用途 | A61K2039/5156; A61K39/0011; A61K48/005; A61P35/00; C07K14/70503; C07K14/7051; C07K16/28; C07K2317/622; C07K2319/03 | August 12, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer